Document:

Exhibit 10.1

​
AMENDMENT NO. 5
to
SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT
​
THIS AMENDMENT NO. 5 TO SECOND AMENDED AND RESTATED LOAN AND
SECURITY AGREEMENT (this “Amendment”) is entered into as of September 24, 2020, by and among XCEL BRANDS, INC., a Delaware corporation (“Initial Borrower”), each other signatory hereto that is a Credit Party under the Loan Agreement (as hereinafter defined), BANK HAPOALIM B.M., as a Lender (“BHI”), and BHI as collateral and administrative agent for Lenders (in such capacity “Agent”).
​
BACKGROUND
​
Initial Borrower, IM Brands, LLC (“IM Brands”), JR Licensing, LLC, H Licensing, LLC, C Wonder Licensing, LLC, Xcel Design Group, LLC, Judith Ripka Fine Jewelry, LLC, H Heritage Licensing, LLC and Xcel-CT MFG, LLC (other than Initial Borrower, collectively, “Guarantors”), Lenders and Agent are parties to a Second Amended and Restated Loan and Security Agreement dated as of February 11, 2019 (as amended, restated, supplemented or otherwise modified from time to time, the “Loan Agreement”) pursuant to which Lenders made term loans to Initial Borrower secured by a Lien on substantially all of the assets of Initial Borrower. Guarantors have guaranteed the payment and performance of Initial Borrower’s obligations to Lenders and Agent under the Loan Agreement which guarantee obligations are secured by a Lien on substantially all of the assets of Guarantors.
​
Initial Borrower has requested that Lenders amend the Loan Agreement and Lenders and Agent have agreed to amend the Loan Agreement on the terms and conditions set forth herein.
​
NOW, THEREFORE, in consideration of the financial accommodations provided to Initial Borrower by Lenders, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
​
1.Definitions. All capitalized terms not otherwise defined herein shall have the meanings given to them in the Loan Agreement.
​
2.Amendments to Loan Agreement. Subject to the satisfaction of the conditions set forth in Section 4 below, the Loan Agreement is amended as follows:
​
(a)Section 1.1 is amended by amending the defined terms “EBITDA” and “Fixed Charge Coverage Ratio” to provide as follows:
​
“EBITDA” means, for the applicable period, for a Person, an amount equal to (a) Net Income for Initial Borrower and the Included Subsidiaries on a consolidated basis for such period, minus, (b) to the extent included in calculating Net Income for Initial Borrower and the Included Subsidiaries on a consolidated basis, the sum of, without duplication, (i) interest income (whether cash or non- cash) for such period, (ii) income tax credits for such period, (iii) gain from extraordinary or non-recurring items for such period (including, without limitation,
​

non-cash items related to purchase accounting) and (iv) deferred compensation payments (regardless of when accrued), plus (c) the following to the extent deducted in calculating such Net Income, (i) interest charges for such period, (ii) the provision for all federal, state, local and foreign taxes payable for such period and the amount of payments permitted pursuant to Section 9(h)(ii), (iii) the amount of depreciation and amortization expense for such period, (iv) the transaction fees, costs and expenses incurred in connection with (A) the negotiation and execution of this Agreement and the other Loan Documents and any amendments thereto and
(B) Permitted Acquisitions, (v) all other extraordinary or non-recurring non-cash charges (including, without limitation, non-cash items related to purchase accounting), (vi) deferred management salaries (accrued but not paid), (vii) all non- cash compensation (including without limitation, stock or equity compensation) in such period and (viii) the amount of the non-cash bad debt reserve taken during the Fiscal Years ending December 31, 2020 and December 31, 2021 relating to the bankruptcy of Lord & Taylor.
​
“Fixed Charge Coverage Ratio” means for any period, as respects any Person, the ratio of (a) EBITDA of such Person for such period plus a decrease in cash in the amount of up to $925,000 expended in connection with the Longaberger Acquisition to (b) the Fixed Charges for such period.
​
		(b)	Section 3.6 is amended in its entirety to provide as follows:

​
“3.6 Voluntary Prepayments. Borrowing Representative shall have the right,  at  any  time  upon  thirty  (30)  day’s  prior  written  notice  to  Agent  to
(a)terminate voluntarily Borrowers’ right to receive or benefit from, and Revolving Lenders’ obligation to make and to incur, Revolving Loans and Letter of Credit Obligations, (b) repay all outstanding Revolving Loans, Letter of Credit Obligations and accrued and unpaid interest thereon or (c) cause Borrowers to prepay all or a portion of the Term Loans or Incremental Term Loans, provided that any prepayment of less than all of the outstanding balance of the Term Loans or Incremental Term Loans shall be applied to the remaining installments of the Term Loans or Incremental Term Loan pro rata in the inverse order of their maturity. If any Term Loan or any Incremental Term Loan is prepaid on or prior to the third anniversary of the Effective Date (including as a result of the occurrence of an Event of Default), Borrowers shall pay to such Lenders the applicable Early Termination Fee. Each Borrower acknowledges and agrees that (i) it would be difficult or impractical to calculate Lenders’ actual damages from early repayment of any Term Loan or Incremental Term Loan, (ii) the Early Termination Fee is intended to be fair and reasonable approximations of such damages, and (iii) the Early Termination Fee is not intended to be a penalty. Notwithstanding the foregoing, in the event that Borrowers make the $750,000 Prepayment, such prepayment shall be applied to installment of the Term Loan due and payable on March 31, 2022 and no Early Termination Fee shall be due and payable in connection therewith.”
​

(c)Section 3.7(a) is amended in its entirety to provide as follows:
​
“(a)  If for any Fiscal Quarter, commencing with Fiscal Quarter ending on March 31, 2021, there shall be Excess Cash Flow for such Fiscal Quarter, then Borrowers shall pay to Agent for the benefit of Lenders holding a portion of the Term Loans an amount equal to fifty percent (50%) of such Excess Cash Flow until the aggregate amount paid for all such Fiscal Quarters equals $4,450,000 (the “Deferred Amount”). If for any Fiscal Year commencing with the Fiscal Year in which Borrowers paid to Agent the entire Deferred Amount, there shall be Excess Cash Flow for such Fiscal Year, then Borrowers shall pay to Agent for the benefit of such Lenders an amount equal to ten percent (10%) of Excess Cash Flow at the end of each Fiscal Year (collectively with the Deferred Amount, the “Cash Flow Recapture Requirement”). The Cash Flow Recapture Requirement for any such Fiscal Quarter or Fiscal Year, as applicable, shall be received by Agent no later than the date that is seven (7) days after the delivery of the Financial Statements for such Fiscal Quarter or Fiscal Year, as applicable, required pursuant to Section 8.1 and, in the event that the Cash Flow Recapture Requirement paid to Agent for all Fiscal Quarters commencing with the Fiscal Quarter ending on March 31, 2021 and ending with the Fiscal Quarter ending March 31, 2022 is less than the Deferred Amount, then Borrower shall pay to Agent the shortfall no later than the date that is seven (7) days after the delivery of the Financial Statements for the Fiscal Quarter ending March 31, 2022 required pursuant to Section 8.1. The Cash Flow Recapture requirement shall be applied to the principal amount of the Term Loan B first in the reverse order of maturity, then to the principal amount of Term Loan A in the reverse order of maturity and after the Term Loans have been paid in full, to the outstanding principal balance of the Incremental Term Loans pro rata with any balance going to pay the outstanding principal balance of the Revolving Loan. Borrowers shall not be required to pay an Early Termination Fee on any amount repaid due to the Cash Flow Recapture Requirement. To the extent applicable, amounts prepaid shall be applied first to any Base Rate Loans then outstanding and then to outstanding LIBOR Rate Loans with the shortest Interest Periods remaining. Together with each prepayment of a LIBOR Rate Loan or a Fixed Rate Loan, Borrowers shall pay any amounts due and payable pursuant to Section 3.12.”
​
​
​
Amendment.

		(d)	Exhibit B-1 (Form of Term Loan Note A) is replaced with Exhibit A to this

(e)Exhibit B-2 (Form of Term Loan Note B) is replaced with Exhibit B-2 to this Amendment.
​
(f)Schedule II (Financial Covenants) is replaced with Schedule II attached to this Amendment.
​
		3.	Conditions  of  Effectiveness.This  Amendment  shall  become  effective  upon

(a)Agent’s receipt of this Amendment duly executed by each Credit Party and each Lender and
(b)Agent’s receipt of Amended and Restated Term Loan Note A and Amended and Restated Term Loan Note B in the form attached to this Amendment duly executed by Initial Borrower.
​

4.Representations and Warranties. Each Credit Party hereby represents and warrants as follows:
​
(a)This Amendment constitutes the legal, valid and binding obligation of such Credit Party and is enforceable against such Credit Party in accordance with its terms, except to the extent that such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors’ rights generally or limiting the right of specific performance.
​
(b)Upon the effectiveness of this Amendment, all representations and warranties of such Credit Party contained in the Loan Documents to which it is a party continue to be true and correct in all material respects as of the date hereof, as if repeated as of the date hereof, except for such representations and warranties which, by their terms, are expressly made only as of a previous date.
​
(c)No Event of Default has occurred and is continuing or would exist after giving effect to this Amendment.
​
(d)No Credit Party has any defense, counterclaim or offset with respect to any of the Loan Documents.
​
		5.	Effect on the Loan Documents.

​

(a)Except as specifically set forth herein, the Loan Documents shall remain in full force and effect, and are hereby ratified and confirmed by each Credit Party a party thereto.
​
(b)Except as specifically set forth herein, the execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of Agent or any Lender nor constitute a waiver of any provision of any Loan Document.
​
6.Governing Law. This Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns and shall be governed by and construed in accordance with the laws of the State of New York.
​
7.Headings. Section headings in this Amendment are included herein for convenience of reference only and shall not constitute a part of this Amendment for any other purpose.
​
8.Counterparts; Electronic Transmission. This Amendment may be executed by the parties hereto in one or more counterparts, each of which shall be deemed an original and all of which when taken together shall constitute one and the same agreement. Any signature delivered by a party by facsimile or other electronic transmission shall be deemed to be an original signature hereto.
​

​
​
IN WITNESS WHEREOF, this Amendment has been duly executed as of the day and year first written above.
​
​
XCEL BRANDS, INC.
​
​
By:  /s/ James Haran
Chief Financial Officer
​
IM BRANDS, LLC
​
By:XCEL BRANDS, INC.,
Its Manager
​
By:  /s/ James Haran
Chief Financial Officer
​
JR LICENSING, LLC
​
By:XCEL BRANDS, INC.,
Its Manager
​
By:  /s/ James Haran
Chief Financial Officer
​
H LICENSING, LLC
​
By:XCEL BRANDS, INC.,
Its Manager
​
By:  /s/ James Haran
Chief Financial Officer
​
​
​
​
​

​
C WONDER LICENSING, LLC
​
By:XCEL BRANDS, INC.,
Its Manager
​
By:  /s/ James Haran
Chief Financial Officer
​
XCEL DESIGN GROUP, LLC By:XCEL BRANDS, INC.,
Its Manager
​
By:  /s/ James Haran
Chief Financial Officer
​
JUDITH RIPKA FINE JEWELRY, LLC By:XCEL BRANDS, INC.,
Its Manager
​
By:  /s/ James Haran
Chief Financial Officer
​
H HERITAGE LICENSING, LLC By:XCEL BRANDS, INC.,
Its Manager
​
By:  /s/ James Haran
Chief Financial Officer
​
​
​
​

XCEL-CT MFG, LLC
​
By:XCEL BRANDS, INC.,
Its Manager
​
​
By:  /s/ James Haran
Chief Financial Officer
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​

BANK HAPOALIM B.M., a Lender and as Agent
​
​
​
By: 
Name: Title:
​
By: 
Name: Title:

       /s/ Lisa Matalon
​
Lisa Matalon
First Vice President
​
​
/s/ Marline Alexander
​

Marline Alexander Senior Vice President
​

​
EXHIBIT B-1
​
[See Attached]
​

​
AMENDED AND RESTATED TERM LOAN NOTE A
​
$7,250,000September 24, 2020
​
This Amended and Restated Term Loan Note A (this “Note”) is executed and delivered under and pursuant to the terms of that certain Second Amended and Restated Loan and Security Agreement dated as of February 11, 2019 (as amended, modified, supplemented or restated from time to time, the “Loan Agreement”) by and among BANK HAPOALIM B.M. (“Lender”), XCEL BRANDS, INC. (“Initial Borrower” and together with each Person who hereafter becomes a Borrower, collectively “Borrowers”), and any other Credit Party executing or becoming a party to the Loan Agreement, the financial institutions party thereto as Lenders and BANK HAPOALIM B.M., as agent for Lenders (in such capacity, “Agent”). Capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Loan Agreement.
​
FOR VALUE RECEIVED, Borrower promises to pay to the order of Lender at the offices of Agent located at 1120 Avenue of the Americas, New York, New York 10036 or at such other place as the holder hereof may from time to time designate to Borrower in writing:
​
(i)the principal sum of Seven Million Two Hundred Fifty Thousand Dollars ($7,250,000), payable, subject to acceleration upon the occurrence of an Event of Default under the Loan Agreement, or earlier termination of the Loan Agreement pursuant to the terms thereof, in quarterly installments commencing on June 30, 2019 and on each March 31, June 30, September 30 and December 31 thereafter in the amounts set forth below for the corresponding period, with the entire unpaid balance due and payable on the Term Loan Maturity Date:
​
	Period

	Amount

	June 30, 2019 – December 31, 2019

	$1,000,000

	June 30, 2020 – December 31, 2020

	$750,000

	March 31, 2021

	$700,000

	June 30, 2021

	$700,000

	September 30, 2021

	$600,000

​
and
​
(ii)interest on the principal amount of this Note from time to time outstanding, payable at the applicable interest rate set forth in the Loan Agreement commencing on March 31, 2019 and on each March 31, June 30, September 30 and December 31 thereafter and upon payment in full of the principal amount of this Note. Upon and after the occurrence of an Event of Default, and during the continuation thereof, interest shall be payable at the applicable Default Rate. In no event, however, shall interest hereunder exceed the maximum interest rate permitted by law.
​
This Note is the Term Loan Note A referred to in the Loan Agreement and is secured, inter alia, by the liens granted pursuant to the Loan Agreement and the other Loan Documents, is entitled to the benefits of the Loan Agreement and the other Loan Documents, and is subject to all of the agreements, terms and conditions therein contained.
​

Payments received by Lender shall be applied against principal and interest as provided for in the Loan Agreement. This Note may be voluntarily prepaid, in whole or in part, on the terms and conditions set forth in the Loan Agreement.
​
If an Event of Default under Section 12.1(f) of the Loan Agreement shall occur, then this Note shall immediately become due and payable, without notice, together with attorneys’ fees if the collection hereof is placed in the hands of an attorney to obtain or enforce payment hereof. If any other Event of Default shall occur under the Loan Agreement or any of the other Loan Documents which is not cured within any applicable grace period, then this Note may, as provided in the Loan Agreement, be declared to be immediately due and payable, without notice, together with attorneys’ fees, if the collection hereof is placed in the hands of an attorney to obtain or enforce payment hereof.
​
This Note shall be governed by and construed in accordance with the laws of the State of New York.
​
To the fullest extent permitted by applicable law, Borrower waives: (a) presentment, demand and protest, and notice of presentment, dishonor, intent to accelerate, acceleration, protest, default, nonpayment, maturity, release, compromise, settlement, extension or renewal of any or all of the Obligations, the Loan Agreement, this Note or any other Loan Documents; (b) all rights to notice and a hearing prior to Agent’s taking possession or control of, or to Agent’s replevy, attachment or levy upon, the Collateral or any bond or security that might be required by any court prior to allowing Agent to exercise any of its remedies; and (c) the benefit of all valuation, appraisal and exemption laws.
​
Borrower acknowledges that this Note is executed as part of a commercial transaction and that the proceeds of this Note will not be used for any personal or consumer purpose.
​
This Note amends and restates and is given in partial substitution for but not in satisfaction of the Amended and Restated Term Loan Note A dated April 13, 2020 executed by Borrower in favor of Lender, in the original principal amount of $7,250,000.
​

​
Borrower agrees to pay to Agent all fees and expenses described in the Loan Agreement and the other Loan Documents.
​
XCEL BRANDS, INC.
​
By: 
Name: Title:
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
19415930SIGNATURE PAGE TO
AMENDED AND RESTATED TERM LOAN NOTE A
​

​
EXHIBIT B-2
​
[See Attached]
​

​
AMENDED AND RESTATED TERM LOAN NOTE B
​
$14,750,000September 24, 2020
​
This Amended and Restated Term Loan Note B (this “Note”) is executed and delivered under and pursuant to the terms of that certain Second Amended and Restated Loan and Security Agreement dated as of February 11, 2019 (as amended, modified, supplemented or restated from time to time, the “Loan Agreement”) by and among BANK HAPOALIM B.M. (“Lender”), XCEL BRANDS, INC. (“Initial Borrower” and together with each Person who hereafter becomes a Borrower, collectively “Borrowers”), and any other Credit Party executing or becoming a party to the Loan Agreement, the financial institutions party thereto as Lenders and BANK HAPOALIM B.M., as agent for Lenders (in such capacity, “Agent”). Capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Loan Agreement.
​
FOR VALUE RECEIVED, Borrower promises to pay to the order of Lender at the offices of Agent located at 1120 Avenue of the Americas, New York, New York 10036 or at such other place as the holder hereof may from time to time designate to Borrower in writing:
​
(i)the principal sum of Fourteen Million Seven Hundred Fifty Thousand Dollars ($14,750,000), payable, subject to acceleration upon the occurrence of an Event of Default under the Loan Agreement, or earlier termination of the Loan Agreement pursuant to the terms thereof, in quarterly installments commencing on June 30, 2021 and on each March 31, June 30, September 30 and December 31 thereafter in the amounts set forth below for the corresponding period, with the entire unpaid balance due and payable on the Term Loan Maturity Date:
​
	Period

	Amount

	September 30, 2021

	$100,000

	December 31, 2021

	$700,000

	March 31, 2022 – December 31, 2022

	$1,125,000

	March 31, 2023 – December 31, 2023

	$1,250,000

​
and
​
(ii)interest on the principal amount of this Note from time to time outstanding, payable at the applicable interest rate set forth in the Loan Agreement commencing on March 31, 2019 and on each March 31, June 30, September 30 and December 31 thereafter and upon payment in full of the principal amount of this Note. Upon and after the occurrence of an Event of Default, and during the continuation thereof, interest shall be payable at the applicable Default Rate. In no event, however, shall interest hereunder exceed the maximum interest rate permitted by law.
​
This Note is the Term Loan Note B referred to in the Loan Agreement and is secured, inter alia, by the liens granted pursuant to the Loan Agreement and the other Loan Documents, is entitled to the benefits of the Loan Agreement and the other Loan Documents, and is subject to all of the agreements, terms and conditions therein contained.
​

Payments received by Lender shall be applied against principal and interest as provided for in the Loan Agreement. This Note may be voluntarily prepaid, in whole or in part, on the terms and conditions set forth in the Loan Agreement.
​
If an Event of Default under Section 12.1(f) of the Loan Agreement shall occur, then this Note shall immediately become due and payable, without notice, together with attorneys’ fees if the collection hereof is placed in the hands of an attorney to obtain or enforce payment hereof. If any other Event of Default shall occur under the Loan Agreement or any of the other Loan Documents which is not cured within any applicable grace period, then this Note may, as provided in the Loan Agreement, be declared to be immediately due and payable, without notice, together with attorneys’ fees, if the collection hereof is placed in the hands of an attorney to obtain or enforce payment hereof.
​
This Note shall be governed by and construed in accordance with the laws of the State of New York.
​
To the fullest extent permitted by applicable law, Borrower waives: (a) presentment, demand and protest, and notice of presentment, dishonor, intent to accelerate, acceleration, protest, default, nonpayment, maturity, release, compromise, settlement, extension or renewal of any or all of the Obligations, the Loan Agreement, this Note or any other Loan Documents; (b) all rights to notice and a hearing prior to Agent’s taking possession or control of, or to Agent’s replevy, attachment or levy upon, the Collateral or any bond or security that might be required by any court prior to allowing Agent to exercise any of its remedies; and (c) the benefit of all valuation, appraisal and exemption laws.
​
Borrower acknowledges that this Note is executed as part of a commercial transaction and that the proceeds of this Note will not be used for any personal or consumer purpose.
​
This Note amends and restates and is given in partial substitution for but not in satisfaction of the Amended and Restated Term Loan Note B dated April 13, 2020 executed by Borrower in favor of Lender, in the original principal amount of $14,750,000.
​

​
Borrower agrees to pay to Agent all fees and expenses described in the Loan Agreement and the other Loan Documents.
​
XCEL BRANDS, INC.
​
By: 
Name: Title:
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
19419585SIGNATURE PAGE TO
AMENDED AND RESTATED TERM LOAN NOTE B
​

SCHEDULE II
​
FINANCIAL COVENANTS
​
1.Minimum Net Worth. Net Worth of Initial Borrower and the Included Subsidiaries on a consolidated basis shall not be less than $90,000,000 at the end of each Fiscal Quarter.
​
2.Minimum Liquid Assets. Liquid Assets of Initial Borrower and the Included Subsidiaries on a consolidated basis shall not be less than the amount set forth below at all times during the applicable Fiscal Quarter:
​
	Fiscal Quarter End
September 30, 2020 and December 31,
2020

	Minimum Liquid Assets
​
$3,000,000

	March 31, 2021, June 30, 2021 and
September 30, 2021

	​
$2,500,000

	December 31, 2021

	$3,000,000

	Each Fiscal Quarter after December 31, 2021

	​
$5,000,000

​

3.Fixed Charge Coverage Ratio. The Fixed Charge Ratio of Initial Borrower and the Included Subsidiaries on a consolidated basis for the twelve Fiscal Month period ending at the end of each Fiscal Quarter set forth below shall not be less than the ratio set forth below for such Fiscal Quarter below:
​
Fiscal QuarterFixed Charge
Coverage Ratio
December 31, 2020 and each Fiscal
Quarter end thereafter1.25 to 1.00
​
​
4.Capital Expenditures. Capital Expenditures of Initial Borrower and the Included Subsidiaries on a consolidated basis in any Fiscal Year shall not exceed the amount set forth below for such Fiscal Year:
​
Fiscal Year EndCapital Expenditures
December 31, 2020$1,600,000
All other times$700,000
​
​
5.Maximum Leverage Ratio. The Leverage Ratio of Initial Borrower and the Included Subsidiaries on a consolidated basis for the twelve Fiscal Month period ending at the end of each Fiscal Quarter shall not exceed the ratio below for such Fiscal Quarter:
​

​
Fiscal QuarterMaximum Leverage Ratio
September 30, 20204.00 to 1.00
December 31, 20203.50 to 1.00
March 31, 20213.15 to 1.00
June 30, 20213.00 to 1.00
September 30, 20212.75 to 1.00
December 31, 20212.50 to 1.00 March 31, 2022 and each Fiscal Quarter
end thereafter1.50 to 1.00
​
​
6.Minimum EBITDA. The EBITDA of Initial Borrower and the Included Subsidiaries on a consolidated basis for the twelve Fiscal Month period ending at the end of each Fiscal Quarter shall be at least the amount set forth below for such Fiscal Quarter:
​
Fiscal Quarter EndMinimum EBITDA
September 30, 2020$5,000,000Exhibit
10.66

 

AMENDED
AND RESTATED

 

SECURITIES
PURCHASE AGREEMENT

 

This
Amended and Restated Securities Purchase Agreement (this “Agreement”) is made and entered into as of
November 9, 2020 (the “Effective Date”) by and among Investview, Inc., a Nevada corporation (the “Company”),
DBR Capital, LLC, a Pennsylvania limited liability company (the “Purchaser”) and, solely for purposes
of Section 3.06 and the other sections expressly referenced therein, Joseph Cammarata (the “Purchasing Assignee”).
Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.

 

RECITALS

 

WHEREAS,
the Company and the Purchaser are parties to that certain Securities Purchase Agreement, dated as of April 27, 2020 (the “Existing
Agreement”), providing for the purchase by the Purchaser, and the sale and issuance by the Company, upon the terms
and conditions set forth therein, of one or more convertible notes of the Company, convertible into shares of common stock of
the Company (the “Common Stock”), upon the terms and subject to the limitations and conditions set forth
therein, and pursuant to which the Purchaser has purchased, and the Company has sold and issued, (i) the First Closing Note (as
defined in the Existing Agreement) in the amount of $1,300,000 dated April 27, 2020 and (ii) the Second Closing Note (as defined
in the Existing Agreement) in the amount of $700,000 dated May 27, 2020 (the First Closing Note and the Second Closing Note are
referred to herein as the “Existing Notes”).

 

WHEREAS,
the Company and the Purchaser desire to modify the terms of the Existing Agreement as further set forth herein to provide for
the purchase by the Purchaser and the sale and issuance by the Company, upon the terms and conditions set forth herein, of one
or more additional convertible notes of the Company, in the form attached hereto as Exhibit A (together with the Amended
and Restated Existing Notes (as defined below) and any note(s) issued in replacement thereof or as a dividend thereon or otherwise
with respect thereto in accordance with the terms thereof, the “Notes”), convertible into shares of
common stock of the Company (the “Common Stock”), upon the terms and subject to the limitations and
conditions set forth in such Notes, and to provide for the modification of the Existing Notes by entering into those certain amended
and restated promissory notes, dated as of the Effective Date (the “Amended and Restated Existing Notes”),
which shall be in the form attached hereto as Exhibit A.

 

NOW,
THEREFORE, in consideration of the foregoing and the mutual representations, warranties and covenants herein contained, the parties
hereto hereby agree as follows:

 

SECTION
2. Sale and Purchase of the Notes.

 

2.01
First Closing Note. On the First Closing Date, upon the terms and subject to the conditions herein contained, the Company
issued and sold to the Purchaser, and the Purchaser purchased from the Company, $1,300,000 aggregate principal amount of Note
(the “First Closing Note”).

 

2.02
Second Closing Note. On the Second Closing Date, upon the terms and subject to the conditions herein contained, the Company
issued and sold to the Purchaser, and the Purchaser purchased from the Company, $700,000 aggregate principal amount of Note (the
“Second Closing Note”).

 

    	 

    	 

    

 

2.03
Third Closing Note. On the Third Closing Date, upon the terms and subject to the conditions herein contained, the Company
agrees to issue and sell to the Purchaser, and the Purchaser agrees to purchase from the Company, $1,300,000 aggregate principal
amount of Note (the “Third Closing Note”).

 

2.04
Fourth Closing Note(s). On the Fourth Closing Date, upon the terms and subject to the conditions herein contained, the
Company agrees to issue and sell to the Purchaser (and the Purchasing Assignee, if applicable), and the Purchaser (and the Purchasing
Assignee, if applicable) agrees to purchase from the Company, $5,700,000 aggregate principal amount of Note(s) (the “Fourth
Closing Note(s)”).

 

2.05
Fifth Closing Note. On the Fifth Closing Date, upon the terms and subject to the conditions herein contained, the Company
agrees to issue and sell to the Purchaser, and the Purchaser agrees to purchase from the Company, $2,000,000 aggregate principal
amount of Note (the “Fifth Closing Note”).

 

2.06
On Third Closing Date, Fourth Closing Date and Fifth Closing Date, the Purchaser (and the Purchasing Assignee, if applicable)
shall pay the purchase price for the applicable Notes to be issued and sold to it at such closing (the “Purchase Price”)
by wire transfer of immediately available funds to the Company, in accordance with the Company’s written wiring instructions,
against delivery of the applicable Note in the principal amount equal to the Purchase Price, and the Company delivered or shall
deliver, as applicable, such duly executed Note on behalf of the Company, to the Purchaser (and the Purchasing Assignee, if applicable),
against delivery of such Purchase Price.

 

SECTION
3. Closings. Subject to the satisfaction of the closing conditions set forth in Section 7:

 

3.01
the closing with respect to the transactions contemplated in Section 2.01 hereof (the “First Closing”)
occurred upon the satisfaction of the terms of this Agreement on April 27, 2020 (the “First Closing Date”);
and

 

3.02
the closing with respect to the transactions contemplated in Section 2.02 hereof (the “Second Closing”)
occurred upon the satisfaction of the terms of this Agreement on May 27, 2020 (the “Second Closing Date”);
and

 

3.03
the closing with respect to the transactions contemplated in Section 2.03 hereof (the closing at which the Third Closing
Note is issued, if any, is referred to herein as the “Third Closing”) shall occur on or prior to November
9, 2020 (which, for the avoidance of doubt, such Third Closing is in Purchaser’s sole discretion, and the Company must effect
the Third Closing pursuant to the satisfaction of the terms of this Agreement) (the “Third Closing Date”);
and

 

3.04
the closing with respect to the transactions contemplated in Section 2.04 hereof (the closing at which the Fourth Closing
Note(s) is/are issued, if any, as applicable, is referred to herein as the “Fourth Closing”) shall occur
on or prior to May 31, 2021 (provided that such date may be extended by up to 30 days by the Purchaser in its sole discretion)
and shall be held on or before the fifth day following delivery of written notice (the “Fourth Closing Notice”)
by the Purchaser to the Company of the Purchaser’s determination to effect the Fourth Closing (which, for the avoidance
of doubt, the Fourth Closing is in Purchaser’s sole discretion to effect or not effect, and the Company must effect the
Fourth Closing upon the receipt of a Fourth Closing Notice pursuant to the satisfaction of the terms of this Agreement) (the “Fourth
Closing Date”), or at such other date as the Company and the Purchaser may agree, remotely via the exchange of documents
and signatures, which Fourth Closing Notice shall set forth the Fourth Closing Date; and

 

    	2

    	 

    

 

3.05
the closing with respect to the transactions contemplated in Section 2.05 hereof (the closing at which the Fifth Closing
Note is issued, if any, is referred to herein as the “Fifth Closing”) shall occur on or prior to August
31, 2021 (provided that such date may be extended by up to 30 days by the Purchaser in its sole discretion) and shall be held
on or before the fifth day following delivery of written notice (the “Fifth Closing Notice”) by the
Purchaser to the Company of the Purchaser’s determination to effect the Fifth Closing (which, for the avoidance of doubt,
the Fifth Closing is in Purchaser’s sole discretion to effect or not effect, and the Company must effect the Fifth Closing
upon the receipt of a Fifth Closing Notice pursuant to the satisfaction of the terms of this Agreement) (the “Fifth
Closing Date” and, together with the First Closing Date, the Second Closing Date, the Third Closing Date and the
Fourth Closing Date, the “Closing Dates” and each a “Closing Date”), or at
such other date as the Company and the Purchaser may agree, remotely via the exchange of documents and signatures, which Fifth
Closing Notice shall set forth the Fifth Closing Date.

 

3.06
With respect to the Fourth Closing, the Purchaser may, in Purchaser’s sole discretion, assign (its “Assignment
Right”) its right and obligation to purchase up to $2,000,000 of the Fourth Closing Note(s) under Section 2.04
and Section 3.04 to the Purchasing Assignee. If the Purchaser desires to exercise its Assignment Right, it shall send
a notice to the Purchasing Assignee at the same time at which it sends the Fourth Closing Notice, which shall include all of the
information set forth in the Fourth Closing Notice, as well as the principal amount of the Fourth Closing Note(s) that the Purchasing
Assignee shall purchase in the Fourth Closing. The Purchasing Assignee hereby agrees that, if the Assignment Right is exercised,
the Purchasing Assignee shall be bound by and subject to the terms of Section 2.04, Section 2.06, Section 3.04
(but, for the avoidance of doubt, the determination to effect the Fourth Closing shall be at the sole discretion of the Purchaser
and not the Purchasing Assignee) and Section 7, and the Purchasing Assignee hereby represents and warrants to the Company
that the statements contained in Section 4 are true and correct as of the Fourth Closing Date as if the Purchasing Assignee
were the Purchaser for all purposes thereunder.

 

SECTION
4. Representations and Warranties of the Purchaser. The Purchaser represents and warrants to the Company that the statements
contained in this Section 4 were, are or will be, as applicable, true and correct as of each Closing Date:

 

4.01
Investment Purpose. The Purchaser is purchasing the Notes, the shares of Common Stock issuable upon conversion of or otherwise
pursuant to the Notes (such shares of Common Stock being collectively referred to herein as the “Conversion Shares”
and, collectively with the Notes and the Conversion Shares, the “Securities”) for its own account and
not with a present view towards the public sale or distribution thereof, except pursuant to sales registered or exempted from
registration under the 1933 Act.

 

4.02
Accredited Investor Status. The Purchaser is an “accredited investor” as that term is defined in Rule 501(a)
of Regulation D.

 

4.03
Reliance on Exemptions. The Purchaser understands that the Securities are being offered and sold to it in reliance upon
specific exemptions from the registration requirements of United States federal and state securities laws and that the Company
is relying upon the truth and accuracy of, and the Purchaser’s compliance with, the representations, warranties, agreements,
acknowledgments and understandings of the Purchaser set forth herein in order to determine the availability of such exemptions
and the eligibility of the Purchaser to acquire the Securities.

 

4.04
Information. The Company has not disclosed to the Purchaser any material nonpublic information and will not disclose such
information unless such information is disclosed to the public prior to or promptly following such disclosure to the Purchaser.

 

    	3

    	 

    

 

4.05
Registration. The Purchaser understands that the Notes and, until such time as the Conversion Shares have been registered
under the 1933 Act or may be sold pursuant to an applicable exemption from registration, the Conversion Shares, may bear a restrictive
legend in substantially the following form:

 

“THE
SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), OR UNDER ANY STATE SECURITIES LAWS, AND MAY NOT BE PLEDGED, SOLD, ASSIGNED, HYPOTHECATED OR OTHERWISE TRANSFERRED
UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES
LAWS OR (2) THE ISSUER OF SUCH SECURITIES RECEIVES AN OPINION OF COUNSEL TO THE HOLDER OF SUCH SECURITIES, WHICH COUNSEL AND OPINION
ARE REASONABLY ACCEPTABLE TO THE ISSUER’S TRANSFER AGENT, THAT SUCH SECURITIES MAY BE PLEDGED, SOLD, ASSIGNED, HYPOTHECATED
OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES
LAWS.”

 

The
legend set forth above shall be removed and the Company shall issue a certificate without such legend to the holder of any Security
upon which it is stamped, if, unless otherwise required by applicable state securities laws, (a) such Security is registered for
sale under an effective registration statement filed under the 1933 Act or otherwise may be sold pursuant to an exemption from
registration without any restriction as to the number of securities as of a particular date that can then be immediately sold,
or (b) such holder provides the Company with an opinion of counsel, in form, substance and scope customary for opinions of counsel
in comparable transactions, to the effect that a public sale or transfer of such Security may be made without registration under
the 1933 Act, which opinion shall be accepted by the Company so that the sale or transfer is effected. In the event that the Company
does not accept the opinion of counsel provided by the Purchaser with respect to the transfer of Securities pursuant to an exemption
from registration, such as Rule 144, at the Deadline (as defined in the Notes), it will be considered an Event of Default pursuant
to Section 3.1(b) of the Notes.

 

4.06
Authorization; Enforcement. This Agreement has been duly and validly authorized. This Agreement has been duly executed
and delivered on behalf of the Purchaser, and this Agreement constitutes a valid and binding agreement of the Purchaser enforceable
in accordance with its terms, except as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance,
and any other laws of general application affecting enforcement of creditors’ rights generally, and as limited by laws relating
to the availability of specific performance, injunctive relief, or other equitable remedies.

 

SECTION
5. Representations and Warranties by the Company. The Company represents and warrants to the Purchaser (and, if Purchaser
exercises its Assignment Right, to Purchasing Assignee) that the statements contained in this Section 5 were, are and will
be, as applicable, true and correct as of each Closing Date (or, as to the Purchasing Assignee, as of the Fourth Closing Date):

 

5.01
SEC Reports. The Company has timely filed all of the reports, schedules, forms, statements and other documents required
to be filed by the Company with the SEC pursuant to the reporting requirements of the 1934 Act (the “SEC Reports”).
The SEC Reports, at the time they were filed with the SEC, (i) complied as to form in all material respects with the requirements
of the 1934 Act and the 1934 Act Regulations and (ii) did not include an untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading.

 

    	4

    	 

    

  

5.02
Independent Accountants. The accountants who certified the audited consolidated financial statements of the Company included
in the SEC Reports are independent public accountants as required by the 1933 Act, the 1933 Act Regulations, the 1934 Act and
the 1934 Act Regulations, and the Public Company Accounting Oversight Board.

 

5.03
Financial Statements; Non-GAAP Financial Measures.

 

(a)
The consolidated financial statements included or incorporated by reference in the SEC Reports, together with the related notes,
present fairly, in all material respects, the financial position of the Company and its consolidated subsidiaries at the dates
indicated and the statement of operations, stockholders’ equity and cash flows of the Company and its consolidated subsidiaries
for the periods specified; said financial statements have been prepared in conformity with U.S. generally accepted accounting
principles (“GAAP”) applied on a consistent basis throughout the periods involved, except in the case
of unaudited, interim financial statements, subject to normal year-end audit adjustments and the exclusion of certain footnotes.

 

(b)
Except as specifically set forth in the financial statements included in the SEC Reports for the fiscal year ending March 31,
2020 (the “2020 Financial Statements”), the Company has no liability or obligation, absolute or contingent,
including without limitation any Indebtedness, except (i) obligations and liabilities incurred after the date of such financial
statements in the ordinary course of business that are not material, individually or in the aggregate, and (ii) obligations under
contracts made in the ordinary course of business that would not be required to be reflected in financial statements prepared
in accordance with general accepted accounting principles.

 

5.04
No Material Adverse Change in Business. Except as otherwise expressly stated in the 2020 Financial Statements, since March
31, 2020, there has been no material adverse change in the condition, financial or otherwise, or in the earnings, business affairs
or business prospects of the Company and its subsidiaries considered as one enterprise, whether or not arising in the ordinary
course of business (a “Material Adverse Effect”), there have been no transactions entered into by the
Company or any of its subsidiaries, other than those in the ordinary course of business and except as contemplated in this Agreement,
which are material with respect to the Company and its subsidiaries considered as one enterprise, and there has been no dividend
or distribution of any kind declared, paid or made by the Company on any class of its capital stock.

 

5.05
Good Standing of the Company. The Company has been duly incorporated and is validly existing as a corporation in good standing
under the laws of the State of Nevada and has corporate power and authority to own, lease and operate its properties and to conduct
its business as disclosed in the SEC Reports and to enter into and perform its obligations under this Agreement; and the Company
is duly qualified as a foreign corporation to transact business and is in good standing in each other jurisdiction in which such
qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where
the failure so to qualify or to be in good standing would not result in a Material Adverse Effect.

 

    	5

    	 

    

 

5.06
Good Standing of Subsidiaries. Each “significant subsidiary” of the Company, as such term is defined in Rule
1-02 of Regulation S-X (each, a “Subsidiary” and, collectively, the “Subsidiaries”)
has been duly incorporated or organized and is validly existing in good standing under the laws of the jurisdiction of its incorporation
or organization, has corporate or similar power and authority to own, lease and operate its properties and to conduct its business
as described in the SEC Reports and is duly qualified to transact business and is in good standing in each jurisdiction in which
such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where
the failure to so qualify or to be in good standing would not result in a Material Adverse Effect. All of the issued and outstanding
capital stock of each Subsidiary has been duly authorized and validly issued, is fully paid and non-assessable and is owned by
the Company, directly or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance, claim
or equity. None of the outstanding shares of capital stock of any Subsidiary were issued in violation of the preemptive or similar
rights of any securityholder of such Subsidiary.

 

5.07
Capitalization; Issuance of Shares.

 

(a)
The Company has an authorized capitalization as set forth in the SEC Reports. The outstanding shares of capital stock of the Company
have been duly authorized and validly issued and are fully paid and non-assessable. None of the outstanding shares of capital
stock of the Company were issued in violation of the preemptive or other similar rights of any securityholder of the Company which
have not been waived. The Conversion Shares are duly authorized and reserved for issuance and, upon conversion of each Note in
accordance with its respective terms, will be validly issued, fully paid and non-assessable, and free from all taxes, liens, claims
and encumbrances with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of shareholders
of the Company and will not impose personal liability upon the holder thereof.

 

(b)
There are no outstanding options, warrants, rights (including conversion or preemptive rights) or agreements for the purchase
or acquisition from the Company of any shares of its capital stock. No stock plan, stock purchase, stock option or other agreement
or understanding between the Company and any holder of any equity securities or rights to purchase equity securities provides
for acceleration or other changes in the vesting provisions or other terms of such agreement or understanding as the result of
(i) termination of employment or consulting services (whether actual or constructive); (ii) any merger, consolidated sale of stock
or assets, change in control or any other transaction(s) by the Company; (iii) the transactions contemplated hereby; or (iv) the
occurrence of any other event or combination of events.

 

5.08
Validity. This Agreement has been duly authorized, executed and delivered by the Company and constitutes a valid and binding
obligation of the Company, enforceable against it in accordance with its terms, except as limited by applicable bankruptcy, insolvency,
reorganization, moratorium, fraudulent conveyance, and any other laws of general application affecting enforcement of creditors’
rights generally, and as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable
remedies. Upon the execution and delivery thereof in accordance herewith, each Note will have been duly authorized, executed and
delivered by the Company and will constitute a valid and binding obligation of the Company, enforceable against it in accordance
with its terms, except as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, and
any other laws of general application affecting enforcement of creditors’ rights generally, and as limited by laws relating
to the availability of specific performance, injunctive relief, or other equitable remedies.

 

    	6

    	 

    

 

5.09
Authorization; Enforcement. (A) The Company has all requisite corporate power and authority to enter into and perform this
Agreement, the Notes and to consummate the transactions contemplated hereby and thereby, and to issue the Notes and Conversion
Shares, in accordance with the terms hereof and thereof, and (B) the execution and delivery of this Agreement and the Notes by
the Company and the consummation by it of the transactions contemplated hereby and thereby (including without limitation, the
issuance of the Notes and the issuance and reservation for issuance of the Conversion Shares issuable upon conversion or exercise
thereof) have been duly authorized by the Company’s Board of Directors and no further consent or authorization of the Company,
its Board of Directors, or its shareholders is required, this Agreement has been duly executed and delivered by the Company by
its authorized representative, and such authorized representative is the true and official representative with authority to sign
this Agreement and the other documents executed in connection herewith and bind the Company accordingly.

 

5.10
Absence of Violations, Defaults and Conflicts. Neither the Company nor any of its subsidiaries is (A) in violation of its
charter, bylaws or similar organizational document, (B) in default in the performance or observance of any obligation, agreement,
covenant or condition contained in any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or
other agreement or instrument to which the Company or any of its subsidiaries is a party or by which it or any of them may be
bound or to which any of the properties or assets of the Company or any subsidiary is subject (collectively, “Agreements
and Instruments”), except for such defaults that would not, singly or in the aggregate, result in liability to the
Company in excess of $50,000, or (C) in violation of any law, statute, rule, regulation, judgment, order, writ or decree of any
arbitrator, court, governmental body, regulatory body, administrative agency or other authority, body or agency having jurisdiction
over the Company or any of its subsidiaries or any of their respective properties, assets or operations (each, a “Governmental
Entity”), except for such violations that would not, singly or in the aggregate, result in liability to the Company
in excess of $50,000. The execution, delivery and performance of this Agreement and the Notes and the consummation of the transactions
contemplated herein and therein (including the issuance and sale of the Securities and the Conversion Shares) and compliance by
the Company with its obligations hereunder and thereunder do not and will not, whether with or without the giving of notice or
passage of time or both, conflict with or constitute a breach of, or default or Repayment Event (as defined below) under, or result
in the creation or imposition of any lien, charge or encumbrance upon any properties or assets of the Company or any subsidiary
pursuant to, the Agreements and Instruments, or require notice to or consent of any party to any agreement or commitment to which
the Company is a party that has not been obtained, nor will such action result in any violation of (i) the provisions of the articles
of incorporation, bylaws or similar organizational document of the Company or any of its subsidiaries or (ii) any applicable law,
statute, rule, regulation, judgment, order, writ or decree of any Governmental Entity. As used herein, a “Repayment
Event” means any event or condition which gives the holder of any note, debenture or other evidence of indebtedness
(or any person acting on such holder’s behalf) the right to require the repurchase, redemption or repayment of all or a
portion of such indebtedness by the Company or any of its subsidiaries.

 

5.11
Absence of Labor Dispute. No labor dispute with the employees of the Company or any of its subsidiaries exists or, to the
knowledge of the Company, is imminent, and the Company is not aware of any existing or imminent labor disturbance by the employees
of any of its or any subsidiary’s principal suppliers, manufacturers, customers or contractors, which, in either case, would
result in a Material Adverse Effect.

 

    	7

    	 

    

 

5.12
Absence of Proceedings. There is no action, suit, proceeding, inquiry or investigation before or brought by any Governmental
Entity now pending or, to the knowledge of the Company, threatened, against or affecting the Company or any of its subsidiaries,
which would reasonably be expected to result in a liability in excess of $50,000, or which would reasonably be expected to adversely
affect the consummation of the transactions contemplated in this Agreement or the Notes or the performance by the Company of its
obligations hereunder and thereunder. The foregoing includes, without limitation, actions pending or, to the Company’s knowledge,
threatened involving the prior employment of any of the Company’s employees, their use in connection with the Company’s
business of any information or techniques allegedly proprietary to any of their former employers, or their obligations under any
agreements with prior employers. The Company is not a party or, to its knowledge, subject to the provisions of any order, writ,
injunction, judgment or decree of any court or government agency or instrumentality.

 

5.13
Absence of Further Requirements. No filing with, or authorization, approval, consent, license, order, registration, qualification
or decree of, any Governmental Entity, and no notice under, or consent pursuant to, any Agreements and Instruments, is necessary
or required for the performance by the Company of its obligations hereunder, in connection with the offering, issuance, or sale
of the Securities hereunder or the consummation of the transactions contemplated by this Agreement, except such as have been already
obtained or as may be required in connection with the formation of NewCo.

 

5.14
Possession of Licenses and Permits. The Company and its subsidiaries possess such permits, licenses, approvals, consents
and other authorizations (collectively, “Governmental Licenses”) issued by the appropriate Governmental
Entities necessary to conduct the business now operated by Company, except where the failure so to possess would not, singly or
in the aggregate, result in a Material Adverse Effect. The Company and its subsidiaries are in compliance with the terms and conditions
of all Governmental Licenses, except where the failure so to comply would not, singly or in the aggregate, result in a Material
Adverse Effect. All of the Governmental Licenses are valid and in full force and effect, except when the invalidity of such Governmental
Licenses or the failure of such Governmental Licenses to be in full force and effect would not, singly or in the aggregate, result
in a Material Adverse Effect. No Governmental License has expired, terminated or been suspended and no Governmental License will
expire, terminate or be suspended within 90 days. Neither the Company nor any of its subsidiaries has received any notice of proceedings
relating to the revocation or modification of any Governmental Licenses which, singly or in the aggregate, if the subject of an
unfavorable decision, ruling or finding, would result in a Material Adverse Effect.

 

5.15
Title to Property. The Company and its subsidiaries do not own any real property. The Company and its subsidiaries have
title to all tangible personal property owned by them, in each case, free and clear of all mortgages, pledges, liens, security
interests, claims, restrictions or encumbrances of any kind except such restrictions and encumbrances as do not, singly or in
the aggregate, materially affect the value of such property and do not materially interfere with the use made and proposed to
be made of such property by the Company or any of its subsidiaries; and all of the leases and subleases material to the business
of the Company and its subsidiaries, considered as one enterprise, and under which the Company or any of its subsidiaries holds
properties, are in full force and effect, and neither the Company nor any such subsidiary has any notice of any material claim
of any sort that has been asserted by anyone adverse to the rights of the Company or any subsidiary under any of the leases or
subleases mentioned above, or affecting or questioning the rights of the Company or such subsidiary to the continued possession
of the leased or subleased premises under any such lease or sublease.

 

    	8

    	 

    

 

5.16
Intellectual Property. The Company and its subsidiaries own or possess the right to use all patents, patent applications,
inventions, licenses, know-how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information
or procedures), trademarks, service marks, trade names, domain names, copyrights, and other intellectual property, and registrations
and applications for registration of any of the foregoing (collectively, “Intellectual Property”) necessary
to conduct their business as presently conducted and currently contemplated to be conducted in the future and, to the knowledge
of the Company, neither the Company nor any of its subsidiaries, whether through their respective products and services or the
conduct of their respective businesses, has infringed, misappropriated, conflicted with or otherwise violated, or is currently
infringing, misappropriating, conflicting with or otherwise violating, and none of the Company or its subsidiaries have received
any heretofore unresolved communication or notice of infringement of, misappropriation of, conflict with or violation of, any
Intellectual Property of any other person or entity. Neither the Company nor any of its subsidiaries has received any communication
or notice (in each case that has not been resolved) alleging that by conducting their business as described in the SEC Reports
or as otherwise currently conducted, such parties would infringe, misappropriate, conflict with, or violate, any of the Intellectual
Property of any other person or entity. The Company knows of no infringement, misappropriation or violation by others of Intellectual
Property owned by or licensed to the Company or its subsidiaries which would reasonably be expected to result in a Material Adverse
Effect. The Company and its subsidiaries have taken all reasonable steps necessary to secure their interests in such Intellectual
Property from their employees and contractors and to protect the confidentiality of all of their confidential information and
trade secrets. None of the Intellectual Property employed by the Company or its subsidiaries has been obtained or is being used
by the Company or its subsidiaries in violation of any contractual obligation binding on the Company or any of its subsidiaries
or, to the knowledge of the Company, any of their respective officers, directors or employees. All Intellectual Property owned
or exclusively licensed by the Company or its subsidiaries is free and clear of all liens, encumbrances, defects or other restrictions
(other than non-exclusive licenses granted in the ordinary course of business). The Company and its subsidiaries are not subject
to any judgment, order, writ, injunction or decree of any court or any Governmental Entity, nor has the Company or any of its
subsidiaries entered into or become a party to any agreement made in settlement of any pending or threatened litigation, which
materially restricts or impairs their use of any Intellectual Property or which would reasonably be expected to result in a Material
Adverse Effect.

 

5.17
Company IT Systems. The Company and its subsidiaries own or have a valid right to access and use all computer systems,
networks, hardware, software, databases, websites, and equipment used to process, store, maintain and operate data, information,
and functions used in connection with the business of the Company and its subsidiaries (the “Company IT Systems”).
The Company IT Systems are adequate for, and operate and perform in all material respects as required in connection with, the
operation of the business of the Company and its subsidiaries as currently conducted. The Company and its subsidiaries have implemented
commercially reasonable backup, security and disaster recovery technology consistent in all material respects with applicable
regulatory standards and customary industry practices.

 

5.18
Cybersecurity. (A) There has been no security breach or other compromise of or relating to the Company IT Systems; (B)
the Company has not been notified of, and has no knowledge of any event or condition that would reasonably be expected to result
in, any such security breach or other compromise of the Company IT Systems; (C) the Company and its subsidiaries have implemented
policies and procedures with respect to the Company IT Systems that are reasonably consistent with industry standards and practices,
or as required by applicable regulatory standards; and (D) the Company and its subsidiaries are presently in material compliance
with all applicable laws or statutes, judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory
authority and contractual obligations relating to the privacy and security of the Company IT Systems and to the protection of
the Company IT Systems from unauthorized use, access, misappropriation or modification.

 

    	9

    	 

    

 

5.19
Environmental Laws. Except as would not, singly or in the aggregate, result in a Material Adverse Effect, (A) neither the
Company nor any of its subsidiaries is in violation of any applicable federal, state, local or foreign statute, law, rule, regulation,
ordinance, code, policy or rule of common law or any judicial or administrative interpretation thereof, including any judicial
or administrative order, consent, decree or judgment, relating to pollution or protection of human health, the environment (including,
without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without
limitation, laws and regulations relating to the release or threatened release of chemicals, pollutants, contaminants, wastes,
toxic substances, hazardous substances, petroleum or petroleum products, asbestos-containing materials or mold (collectively,
“Hazardous Materials”) or to the manufacture, processing, distribution, use, treatment, storage, disposal,
transport or handling of Hazardous Materials (collectively, “Environmental Laws”), (B) the Company and
its subsidiaries have all permits, authorizations and approvals required for their operations under any applicable Environmental
Laws and are each in compliance with their requirements, (C) there are no pending or, to the knowledge of the Company, threatened
administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation,
investigations or proceedings relating to any Environmental Law against the Company or any of its subsidiaries and (D) to the
knowledge of the Company, there are no events or circumstances that would reasonably be expected to form the basis of an order
for clean-up or remediation, or an action, suit or proceeding by any private party or Governmental Entity, against or affecting
the Company or any of its subsidiaries relating to Hazardous Materials or any Environmental Laws.

 

5.20
Accounting Controls and Disclosure Controls. Except as set forth in the Company’s SEC Reports, the Company and its
subsidiaries maintain effective internal control over financial reporting (as defined under Rule 13a-15 and 15d-15 under the 1934
Act Regulations) and a system of internal accounting controls sufficient to provide reasonable assurances that (A) transactions
are executed in accordance with management’s general or specific authorization; (B) transactions are recorded as necessary
to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets; (C) access to
assets is permitted only in accordance with management’s general or specific authorization; and (D) the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
Since the end of the Company’s most recent audited fiscal year, there has been (1) no material weakness in the Company’s
internal control over financial reporting (whether or not remediated) and (2) no change in the Company’s internal control
over financial reporting that has materially adversely affected, or is reasonably likely to materially adversely affect, the Company’s
internal control over financial reporting.

 

5.21
Compliance with the Sarbanes-Oxley Act. The Company is in compliance in all material respects with all provisions of the
Sarbanes-Oxley Act of 2002 and all rules and regulations promulgated thereunder or implementing the provisions thereof that are
in effect and with which the Company is required to comply.

 

5.22
Payment of Taxes. All United States federal income tax returns of the Company and its subsidiaries required by law to be
filed have been filed and all taxes shown by such returns or otherwise assessed, which are due and payable, have been paid, except
assessments against which appeals have been or will be promptly taken and as to which adequate reserves have been provided. No
assessment in connection with United States federal tax returns has been made against the Company. The Company and its subsidiaries
have filed all other tax returns that are required to have been filed by them or have timely requested extensions thereof pursuant
to applicable foreign state, local or other law and have paid all taxes due pursuant to such returns or all taxes due and payable
pursuant to any assessment received by the Company and its subsidiaries, except for such taxes, if any, as are being contested
in good faith and as to which adequate reserves have been established by the Company or its subsidiaries.

 

    	10

    	 

    

 

The
charges, accruals and reserves on the books of the Company in respect of any income and corporation tax liability for any years
not finally determined have been determined in accordance with GAAP and are reasonably expected by the Company to be adequate
to meet any assessments or reassessments for additional income tax for any years not finally determined.

 

5.23
ERISA. (i) At no time in the past six years has the Company or any ERISA Affiliate maintained, sponsored, participated
in, contributed to or had any liability or obligation in respect of any Employee Benefit Plan subject to Title IV of ERISA or
Section 412 of the Code, any “multiemployer plan” as defined in Section 3(37) of ERISA or any multiple employer plan
for which the Company or any ERISA Affiliate has incurred or could incur material liability under Section 4063 or 4064 of ERISA,
(ii) no “welfare benefit plan” as defined in Section 3(1) of ERISA provides or promises, or at any time provided or
promised, retiree health, or other post-termination benefits except to the extent such benefit is fully insured or as may be required
by the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, or similar state law and (iii) each Employee Benefit
Plan is and has been operated in compliance with its terms and all applicable laws, including but not limited to ERISA and the
Code. Each Employee Benefit Plan intended to be qualified under Code Section 401(a) has a favorable determination or opinion letter
from the Internal Revenue Service (the “IRS”) upon which it can rely, and any such determination or
opinion letter remains in effect and has not been revoked and no event has occurred and no facts or circumstances exist that could
reasonably be expected to result in the loss of qualification or tax exemption of any such Employee Benefit Plan. With respect
to each Foreign Benefit Plan, such Foreign Benefit Plan (1) if intended to qualify for special tax treatment, meets, in all material
respects, the requirements for such treatment, and (2) if required to be funded, is funded to the extent required by applicable
law. The Company does not have any obligations under any collective bargaining agreement with any union. As used in this Section
5.23, “Code” means the Internal Revenue Code of 1986, as amended; “Employee Benefit
Plan” means any “employee benefit plan” within the meaning of Section 3(3) of ERISA, including, without
limitation, all equity and equity-based, severance, employment, change-in-control, medical, disability, fringe benefit, bonus,
incentive, deferred compensation, employee loan and all other employee benefit plans, agreements, programs, policies or other
arrangements, whether or not subject to ERISA, under which (x) any current or former employee, director, independent contractor
or other service provider of the Company or its subsidiaries has any present or future right to benefits and which are contributed
to, sponsored by or maintained by the Company or any of the Subsidiaries or (y) the Company or any of the Subsidiaries has had
or has any present or future direct or contingent obligation or liability; “ERISA” means the Employee
Retirement Income Security Act of 1974, as amended; “ERISA Affiliate” means any member of the company’s
controlled group as determined pursuant to Code Section 414(b), (c), (m) or (o), with respect to any Person, each business or
entity under “common control” with such Person within the meaning of Section 4001(a)(14) of ERISA; and “Foreign
Benefit Plan” means any Employee Benefit Plan established, maintained or contributed to outside of the United States
of America and which is not subject to United States law.

 

5.24
Insurance. The Company and its subsidiaries carry or are entitled to the benefits of insurance, with what the Company reasonably
believes to be financially sound and reputable insurers, in such amounts and covering such risks as is adequate for the conduct
of their respective businesses and the value of their respective properties and assets, and all such insurance is in full force
and effect. The Company has no reason to believe that it or any of its subsidiaries will not be able (A) to renew its existing
insurance coverage as and when such policies expire or (B) to obtain comparable coverage from similar institutions as may be necessary
or appropriate to conduct its business as now conducted and at a cost that is comparable to its existing cost.

 

5.25
Investment Company Act. The Company is not required, and upon the issuance and sale of the Securities will not be required,
to register as an “investment company” under the Investment Company Act of 1940, as amended (the “1940
Act”).

 

    	11

    	 

    

 

5.26
No Unlawful Payments. None of the Company, any of its subsidiaries or, to the knowledge of the Company, any director, officer,
agent, employee, Affiliate or other person acting on behalf of the Company or any of its subsidiaries has taken any action, directly
or indirectly, that would result in a violation of any applicable anti-corruption laws, including, without limitation, making
use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise
to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving
of anything of value to any “government official” (including any officer or employee of a government or government-owned
or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf
of any of the foregoing, or any political party or party official or candidate for political office) in violation of any applicable
anti-corruption laws, and the Company and its subsidiaries have conducted their businesses in compliance with applicable anti-corruption
laws and have instituted and maintain policies and procedures designed to ensure continued compliance therewith.

 

5.27
Compliance with Anti-Money Laundering Laws. The operations of the Company and its subsidiaries are and have been conducted
at all times in compliance in all material respects with applicable financial recordkeeping and reporting requirements of the
Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all applicable jurisdictions,
the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced
by any Governmental Entity (collectively, the “Anti-Money Laundering Laws”); and no action, suit or
proceeding by or before any Governmental Entity involving the Company or any of its subsidiaries with respect to the Anti-Money
Laundering Laws is pending or, to the knowledge of the Company, threatened.

 

5.28
No Conflicts with Sanctions Laws. None of the Company, any of its subsidiaries or, to the knowledge of the Company, any
director, officer, agent, employee, Affiliate or other person acting on behalf of the Company or any of its subsidiaries is a
Person currently the subject or target of any sanctions administered or enforced by the United States Government, including, without
limitation, the U.S. Department of the Treasury’s Office of Foreign Assets Control, the United Nations Security Council,
the European Union, Her Majesty’s Treasury, or other relevant sanctions authority (collectively, “Sanctions”),
nor is the Company or any of its subsidiaries located, organized or resident in a country or territory that is the subject of
Sanctions; and the Company will not knowingly directly or indirectly use the proceeds of the sale of the Securities, or lend,
contribute or otherwise make available such proceeds to any subsidiaries, joint venture partners or other Person, to fund any
activities of or the business with any Person, or in any country or territory, that, at the time of such funding, is the subject
of Sanctions or in any other manner that will result in violation by any Person of Sanctions.

 

5.29
Private Placement. Neither the Company nor its subsidiaries, nor any person acting on its or their behalf, has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security under any circumstances that
would require registration under the 1933 Act of the Securities being sold pursuant to this Agreement. Assuming the accuracy of
the representations and warranties of the Purchaser contained in Section 4 hereof, the issuance of the Securities, including
the issuance of the Conversion Shares, is exempt from registration under the 1933 Act.

 

5.30 Transactions
with Affiliates. Neither the Company nor any of its subsidiaries is a party to any agreement, written or oral, to sell,
lease or otherwise transfer any property or assets to, or purchase, lease or otherwise acquire any property or assets from,
or otherwise engage in any other transactions with, any of its employees, officers, directors, former employees, officers or
directors, or Affiliates, except in the ordinary course of business at prices and on terms and conditions not less favorable
to the Company or such Subsidiary than could be obtained on an arm’s-length basis from unrelated third parties and
which has been disclosed in writing to the Purchaser. Neither the Company nor any of its subsidiaries has liability or
obligation, absolute or contingent, including without limitation any Indebtedness, to any of its employees, officers,
directors, former employees, officers or directors, or Affiliates, except (i) current employee compensation payable in the
ordinary course for amounts which have not accrued more than 30 days or as disclosed in writing to the Purchaser.

 

    	12

    	 

    

 

5.31
Registration Rights; Voting Agreements. Except as required pursuant to Section 8 of this Agreement and except as
shall be entered into with Purchaser in connection herewith, (a) the Company is presently not under any obligation, and has not
granted any rights, to register under the 1933 Act any of the Company’s presently outstanding securities or any of its securities
that may hereafter be issued that have not expired or been satisfied, (b) no shareholder of the Company has entered into any agreements
to which the Company is a party with respect to the voting of shares of capital stock of the Company and (c) the Company is not
subject to or a party to any agreement providing any holder of securities of the Company or its subsidiaries with preemptive rights,
approval rights or similar arrangements, other than as provided in the articles of incorporation of the Company as currently in
effect.

 

SECTION
6. Covenants.

 

6.01
Reasonable Best Efforts. Each party shall use its reasonable best efforts to timely satisfy each of the conditions to be
satisfied by it as provided in Section 7 of this Agreement.

 

6.02
Use of Proceeds. The Company used the proceeds from the sale of (i) the First Closing Note to either (A) make a $1,300,000
contribution to SafeTek solely for the prompt purchase by SafeTek of Bitmain Equipment or (B) repay $1,300,000 aggregate principal
indebtedness of the Company advanced by Joseph Cammarata on or about April 23, 2020 and used by the Company to acquire Bitmain
Equipment and (ii) the Second Closing Note to repay $700,000 aggregate principal amount of outstanding indebtedness of the Company.
The Company shall use the proceeds from the sale of (i) the Third Closing Note to make a $1,300,000 contribution to SafeTek solely
for the prompt purchase by SafeTek of highly qualified computing chip processor equipment for Blockchain cryptocurrency mining,
(ii) the Fourth Closing Note(s) to be used solely for the purposes of the Company’s Crypto-Currency Mining and Blockchain
Technology business operations and proposals, as reviewed and approved by the Company’s Board of Directors, and (iii) the
Fifth Closing Note to be used by the Company to satisfy the Company’s obligation under that certain Subscription Agreement
to be entered into by and between the Company and LevelX Holdings Group, LLC.

 

6.03
Disclosure of Transactions and Other Material Information. Within the applicable period of time required by the 1934 Act,
the Company shall file a Current Report on Form 8-K describing the terms and conditions of the transactions contemplated by this
Agreement in the form required by the 1934 Act. The Company shall provide the Purchaser with a reasonable opportunity to review
and provide comments on the draft of such 8-K filing. The Company shall be permitted to issue press releases or other public statement
with respect to the transactions contemplated hereby, provided that the Company shall not publicly disclose the name of the Purchaser
or an Affiliate of the Purchaser except as otherwise provided in this Section 6.03. Notwithstanding the foregoing, and
unless required by the rules and regulations of the SEC or otherwise agreed to in writing by the Company and the Purchaser, the
Company shall not publicly disclose the name of the Purchaser or an Affiliate of the Purchaser, or include the name of the Purchaser
or an Affiliate of the Purchaser in any press release or filing with the SEC or any regulatory agency or the Principal Trading
Market, without the prior written consent of such Purchaser.

 

    	13

    	 

    

 

6.04
Expenses. Each of the Company and the Purchaser is liable for, and will pay, its own expenses incurred in connection with
the negotiation, preparation, execution and delivery of this Agreement, including, without limitation, attorneys’ and consultants’
fees and expenses, except that (i) to assist Company, the Purchaser has agreed to advance funds on behalf of Company for the Company’s
reasonable legal fees and other direct expenses incurred in connection with preparation, execution and delivery of the Transaction
Documents and (ii) the Company shall reimburse the Purchaser, upon Purchaser’s demand, an amount up to $40,000.00 for reasonable
legal fees and other direct expenses incurred in connection with the negotiation, preparation, execution and delivery of this
Agreement.

 

6.05
Reservation of Common Stock. The Company shall take all action necessary to at all times have authorized, and reserved
for the purpose of issuance, the Conversion Shares.

 

6.06
Investor Rights Agreement; Voting Agreement; Security Agreement; Lock-Up Agreements; Series B Consent; Opinion of Counsel.

 

(a)
Concurrently with the execution of the Existing Agreement, (i) the Company and the Purchaser entered into an investor rights agreement,
in the form attached hereto as Exhibit B (the “Investor Rights Agreement”), (ii) the Company,
certain key stockholders of the Company and the Purchaser entered into a voting agreement, in the form attached hereto as Exhibit
C (the “Voting Agreement”) and (iii) certain officers and stockholders of the Company entered into
lock-up agreements, in the form attached hereto as Exhibit D (the “Lock-Up Agreements”).

 

(b)
Promptly after the execution of the Existing Agreement and in any event not later than May 15, 2020, (a) the Company, SafeTek
and the Purchaser entered into a guaranty and collateral agreement, in the form attached hereto as Exhibit E (the “Security
Agreement”), (b) the Company obtained from all of the holders of the Company’s 13% Series B Cumulative Redeemable
Perpetual Preferred Stock written evidence of consent to the issuance of the Notes and the transactions contemplated by this Agreement
and waiver of any preemptive or other rights to receive Notes or similar instruments in connection with this Agreement and the
transactions contemplated hereunder, in form and substance satisfactory to the Purchaser (the “Series B Consent”)
and (c) the Company delivered to the Purchaser the opinion of Michael Best & Friedrich LLP, counsel for the Company, or such
other counsel for the Company acceptable to the Purchaser in its sole and absolute discretion, dated as of the First Closing Date
addressing corporate authority, due execution and delivery, enforceability, the creation and perfection security interests, the
absence of conflicts and such other matters as the Purchaser shall reasonably request, which opinion shall be in form and substance
satisfactory to the Purchaser.

 

(c)
On the Effective Date, (i) the Company and the Purchaser shall enter into the Amended and Restated Existing Notes, (ii) the Company
and the Purchaser shall enter into an amendment to the Investor Rights Agreement, in the form attached hereto as Exhibit F
(the “Investor Rights Agreement Amendment”), (iii) the Company, certain key stockholder of the Company
and the Purchaser shall enter into an amendment to the Voting Agreement, in the form attached hereto as Exhibit G (the
“Voting Agreement Amendment”) and (iv) the Company, certain employees of the Company and the Purchaser
shall enter into a pledge agreement, in the form attached hereto as Exhibit I (the “Pledge Agreement”).

 

6.07 Broker-Dealer
Subsidiary. Not later than 30 days following the Third Closing Date, the Company, Purchaser and SSA Technologies LLC
shall finalize and execute all required documentation to establish LevelX Holdings Group, LLC and to cause such entity to
form or obtain a subsidiary (“NewCo”) to act as a broker-dealer, and shall promptly take all
actions necessary to register such entity with the SEC as a broker-dealer under the 1934 Act. The proceeds allocated by Section
6.02(iii) for the satisfaction of the Company’s obligations under the Subscription Agreement noted in such Section
shall be used for development and operation of a U.S. and non-U.S. brokerage and financial services firm intended to deliver
professional trading services catering primarily to a diverse base of self-directed (DIY) and active online brokerage
investors, professional fund managers, buy-side professionals, and registered investment advisors (the
“Broker-Dealer Business”). The structure and organizational documents of LevelX Holdings Group, LLC ,
including all terms and conditions of the equity structure thereof, shall be acceptable in form and substance to the
Purchaser, and shall provide that the majority of the board of directors or similar management body shall be appointed by the
Purchaser, notwithstanding any dilution of the Purchaser’s interests, and shall closely be in accordance with the
Proposed Merger Summary of Principal Terms executed by Company, Purchaser and LevelX Capital LLC on or about August 13,
2020.

 

    	14

    	 

    

 

6.08
Joinder to Guaranty and Collateral Agreement. Not later than 30 days following the Third Closing Date, the Company will
cause each of its subsidiaries not currently a party thereto to execute a joinder (the “Security Agreement Joinder”)
to join as a “guarantor” and “grantor” that certain Guaranty and Collateral Agreement, dated as of May
15, 2020, among the Company, Safetek, LLC and the Purchaser.

 

SECTION
7. Conditions of Purchaser’s Obligations.

 

7.01
Conditions of the Purchaser’s Obligations at each Closing. The obligations of the Purchaser (and the Purchasing Assignee,
if applicable) under Section 2 hereof are subject to the fulfillment, at or prior to the applicable Closing, of all of
the following conditions, any of which may be waived in whole or in part by the Purchaser (on behalf of itself and the Purchasing
Assignee, if applicable) in Purchaser’s sole and absolute discretion.

 

(a)
Representations and Warranties. The representations and warranties of the Company contained in this Agreement shall be
true and correct on and as of the Closing Date with the same effect as though such representations and warranties had been made
on and as of the Closing Date (except to the extent expressly made as of an earlier date in which case as of such earlier date).

 

(b)
Performance. The Company shall have performed and complied with all covenants, agreements, obligations and conditions contained
in this Agreement that are required to be performed or complied with by it on or prior to the Closing Date.

 

(c)
Compliance Certificate. The Chief Executive Officer of the Company shall have delivered to the Purchaser (and the Purchasing
Assignee, if applicable) at the Closing Date a certificate certifying that the conditions specified in Sections 7.01(a)
and 7.01(b) of this Agreement have been fulfilled.

 

(d)
Qualification under State Securities Laws. All registrations, qualifications, permits and approvals, if any, required under
applicable state securities laws shall have been obtained by Company for the lawful execution, delivery and performance of this
Agreement.

 

(e)
Adverse Changes. The Purchaser shall have determined, in its sole discretion, that there have not been any events, conditions
or changes, material, adverse or otherwise, that are reasonably likely to result in changes to the condition, financial or otherwise,
earnings, business affairs or prospects of the Company or any of its subsidiaries.

 

    	15

    	 

    

 

7.02
Conditions of the Purchaser’s Obligations at Third Closing. In addition to the conditions set forth in Section
7.01 above, the obligations of the Purchaser under Section 2 hereof are subject to the fulfillment, at or prior to
the Third Closing, of all of the following conditions, any of which may be waived in whole or in part by the Purchaser in its
sole and absolute discretion.

 

(a)
Secretary’s Certificate. The Secretary of the Company shall have delivered to the Purchaser at the Third Closing
Date a certificate certifying (i) the Articles of Incorporation, as amended, of the Company; (ii) the Bylaws of the Company; and
(iii) resolutions of the Board of Directors approving this Agreement and the transactions contemplated by this Agreement.

 

(b)
Modification of 2020 Incentive Plan and Grant of Awards. The Company shall have modified the InvestView, Inc. 2020 Incentive
Plan to increase the number of shares subject thereto sufficient to allow additional Restricted Share Awards (as defined therein)
in the aggregate amount of 175,000,000 and to allow a vesting period of one, two and three years, and the Board of Directors shall
have granted Restricted Share Awards to the current members of the Board of Directors in an aggregate amount of 175,000,000, with
a vesting period and allocated among the directors in a manner satisfactory to the Purchaser.

 

7.03
Conditions of the Purchaser’s Obligations at the Fifth Closing. In addition to the conditions set forth in Section
7.01 above, the obligations of the Purchaser under Section 2.05 hereof are subject to the fulfillment, at or prior
to the Fifth Closing, of all of the following conditions, any of which may be waived in whole or in part by the Purchaser in its
absolute discretion.

 

(a)
Company Contribution. The Company shall contribute $2,000,000 to LevelX Holdings Group, LLC promptly after the Fifth Closing,
and such funds shall be used as provided in Section 6.02(c)(iii) above.

 

(b)
SSA Technologies LLC Contribution. Within thirty (30) days of the Third Closing, SSA Technologies LLC shall contribute
to LevelX Holdings Group, LLC its broker-dealer subsidiary and associated licenses with an aggregate value of approximately $1,000,000
to NewCo.

 

SECTION
8. Transfer Agent Instructions. The Company shall issue irrevocable instructions to its transfer agent to issue
certificates, registered in the name of the Purchaser or its nominee (and the Purchasing Assignee or his nominee, if
applicable), for the Conversion Shares in such amounts as specified from time to time by the Purchaser (or the Purchasing
Assignee, if applicable) to the Company upon conversion of the Notes in accordance with the terms thereof (the
“Irrevocable Transfer Agent Instructions”). In the event that the Company proposes to replace its
transfer agent, the Company shall provide, prior to the effective date of such replacement, a fully executed Irrevocable
Transfer Agent Instructions in a form as initially delivered pursuant to this Agreement (including but not limited to the
provision to irrevocably reserve shares of Common Stock in the Reserved Amount as such term is defined in the Notes) signed
by the successor transfer agent to Company and the Company. Prior to registration of the Conversion Shares under the 1933 Act
or the date on which the Conversion Shares may be sold pursuant to an exemption from registration, all such certificates
shall bear the restrictive legend specified in Section 4.05 of this Agreement. The Company warrants that: (i) no
instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section 8, will be given by the
Company to its transfer agent and that the Securities shall otherwise be freely transferable on the books and records of the
Company as and to the extent provided in this Agreement and the Notes; (ii) it will not direct its transfer agent not to
transfer or delay, impair, and/or hinder its transfer agent in transferring (or issuing)(electronically or in certificated
form) any certificate for Conversion Shares to be issued to the Purchaser (or the Purchasing Assignee, if applicable) upon
conversion of or otherwise pursuant to the Notes as and when required by the Notes and this Agreement; and (iii) it will not
fail to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from
removing) any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any certificate for
any Conversion Shares issued to the Purchaser (or the Purchasing Assignee, if applicable) upon conversion of or otherwise
pursuant to the Notes as and when required by the Notes and/or this Agreement. If the Purchaser (or the Purchasing Assignee,
if applicable) provides the Company and the Company’s transfer agent, at the cost of the Purchaser (or the Purchasing
Assignee, if applicable), with an opinion of counsel in form, substance and scope customary for opinions in comparable
transactions, to the effect that a public sale or transfer of such Securities may be made without registration under the 1933
Act, the Company shall permit the transfer, and, in the case of the Conversion Shares, promptly instruct its transfer agent
to issue one or more certificates, free from restrictive legend, in such name and in such denominations as specified by the
Purchaser (or the Purchasing Assignee, if applicable). The Company acknowledges that a breach by it of its obligations
hereunder will cause irreparable harm to the Purchaser (or the Purchasing Assignee, if applicable), by vitiating the intent
and purpose of the transactions contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for a
breach of its obligations under this Section 8 may be inadequate and agrees, in the event of a breach or threatened
breach by the Company of the provisions of this Section, that the Purchaser (or the Purchasing Assignee, if applicable) shall
be entitled, in addition to all other available remedies, to an injunction restraining any breach and requiring immediate
transfer, without the necessity of showing economic loss and without any bond or other security being required.

 

    	16

    	 

    

 

SECTION
9. Issuance of Shares. In addition to any and all other rights and remedies provided under this Agreement, the Notes and
each of the other Transaction Documents, the Company hereby absolutely, irrevocably and unconditionally agrees and covenants that,
upon the occurrence of an Event of Default (as defined in the Notes) under any Note and upon demand by the Purchaser, the Company
shall issue to the Purchaser up to Seven Hundred and Twenty Million (720,000,000) shares of non-registered common stock of the
Company (the “Shares”), in accordance with the terms of this Section 9.

 

9.01
Number of Shares. The aggregate number of Shares to be issued to the Purchaser pursuant to this Section 9 as of the date
hereof shall be 104,000,000, which number shall increase to a total of 560,000,000 if and when the Fourth Closing occurs and a
total of 720,000,000 if and when the Fifth Closing occurs.

 

9.02
Registration Rights. Upon the issuance of the Shares to the Purchaser, the Shares shall be deemed “Registrable Securities”
under the Investor Rights Agreement.

 

9.03
Authorized Shares. The Company covenants that from the Effective Date through the date that the Notes are repaid in full,
the Conversion (as defined in the Notes) under each Note is complete or the issuance of the Shares pursuant to this Section
9 is complete, as applicable, the Company will reserve from its authorized and unissued common stock that number of Shares
subject to issuance pursuant to Section 9.01 (the “Reserved Amount”). The Company represents
that upon issuance, the Shares will be duly and validly issued, fully paid and non-assessable. In addition, if the Company shall
issue any securities or make any change to its capital structure, including any stock split, reverse stock split or similar event,
the Company shall at the same time make proper provision so that thereafter there shall be a sufficient number of shares of common
stock authorized and reserved, free from preemptive rights, issuance under this Section 9. The Company (i) acknowledges
that it has irrevocably instructed its transfer agent to issue certificates for the common stock issuable pursuant to this Section
9, and (ii) agrees that the execution of this Agreement shall constitute full authority to its officers and agents who are
charged with the duty of executing stock certificates to execute and issue the necessary certificates for issuance of the Shares.
If at any time the Company fails to maintain the Reserved Amount it will be considered an Event of Default under Section 3.1(a)
of each of the Notes then issued and outstanding.

 

    	17

    	 

    

 

9.04
Further Assurances. The Company hereby agrees to do such further acts and things and to promptly execute and deliver to
the Purchaser such additional agreements and instruments as the Purchaser may reasonably require or deem reasonably advisable
to carry into effect the purpose of this Section 9.04 or to further assure and confirm unto the Purchaser its rights, powers
and remedies hereunder.

 

SECTION
10. Events of Default and Remedies. The occurrence of an Event of Default (as defined in the Notes) under any Note shall
constitute an event of default hereunder and, in addition to all rights and remedies provided in each of the Transaction Documents,
the Purchaser shall have the right to terminate all commitments of the Purchaser hereunder.

 

SECTION
11. Definitions. Unless the context otherwise requires, the terms defined in this Section 11 shall have the meanings
specified for all purposes of this Agreement. All accounting terms used in this Agreement, whether or not defined in this Section
11, shall be construed in accordance with GAAP and such accounting terms shall be determined on a consolidated basis for the
Company and each of its subsidiaries, and the financial statements and other financial information to be furnished by the Company
pursuant to this Agreement shall be consolidated and presented with consolidating financial statements of the Company and each
of its subsidiaries.

 

“1933
Act Regulations” means the rules and regulations promulgated under the 1933 Act.

 

“1934
Act” means the Securities Exchange Act of 1934, as amended.

 

“1934
Act Regulations” means the rules and regulations promulgated under the 1934 Act.

 

“Affiliate”
shall have the meaning ascribed to such term in Rule 12b-2 of the General Rules and Regulations under the 1934 Act.

 

“Bitmain
Equipment” means the purchase and operation of highly qualified computing chip processor equipment for Blockchain
cryptocurrency mining.

 

“Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in the City of New York are
authorized or required by law to remain closed.

 

“Change
of Control” means:

 

(1)
any “person” or “group” of related persons (as such terms are used in Sections 13(d) and 14(d) of the
Exchange Act), other than a Permitted Holder, becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 under the Exchange
Act, except that such person or group shall be deemed to have “beneficial ownership” of all shares that any such person
or group has the right to acquire, whether such right is exercisable immediately or only after the passage of time), directly
or indirectly, of more than 50% of the total voting power of the voting stock of the Company; or

 

(2)
the merger or consolidation of the Company with or into another Person or the merger of another Person with or into the Company
or the merger of any Person with or into a Subsidiary of the Company, unless the holders of a majority of the aggregate voting
power of the voting stock of the Company, immediately prior to such transaction, hold securities of the surviving or transferee
Person that represent, immediately after such transaction, at least a majority of the aggregate voting power of the voting stock
of the surviving or transferee Person;

 

(3)
the adoption by the shareholders of the Company of a plan or proposal for the liquidation or dissolution of the Company; or

 

    	18

    	 

    

 

(4)
Joseph Cammarata ceases to be chief executive officer of the Company or ceases to fulfill the duties of such role and a successor
chief executive officer acceptable to the Purchaser shall not have been appointed within 90 days.

 

“Indebtedness”
means, with respect to any Person, without duplication, (a) all indebtedness of such Person for borrowed money; (b) all obligations
of such Person for the deferred purchase price of property or services (other than trade payables or other accounts payable incurred
in the ordinary course of such Person’s business); (c) all obligations of such Person evidenced by bonds, debentures, notes
or other similar instruments or upon which interest payments are customarily made; (d) all reimbursement, payment or other obligations
and liabilities of such Person created or arising under any conditional sales or other title retention agreement with respect
to property used and/or acquired by such Person, even though the rights and remedies of the lessor, seller and/or lender thereunder
may be limited to repossession or sale of such property; (e) all capitalized lease obligations of such Person; (f) all unpaid
reimbursement obligations and liabilities, contingent or otherwise, of such Person, in respect of letters of credit, acceptances
and similar facilities; (g) all obligations and liabilities, calculated on a basis reasonably satisfactory to the Purchaser and
in accordance with accepted practice, of such Person under hedging agreements; (h) all monetary obligations under any receivables
factoring, receivable sales or similar transactions and all monetary obligations under any synthetic lease, tax ownership lease,
off-balance sheet financing or similar financing; and (i) all obligations referred to in clauses (a) through (h) of this definition
of another Person secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to
be secured by) a lien, charge or encumbrance upon property owned by such Person, even though such Person has not assumed or become
liable for the payment of such Indebtedness.

 

“Permitted
Holder” means any of Joseph Cammarata, the Purchaser, David B. Rothrock, or any of Purchaser’s subsidiaries
or affiliates.

 

“Person”
means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, a trust
(including any beneficiary thereof), a joint venture, an unincorporated organization, and a governmental entity or any department,
agency, or political subdivision thereof.

 

“Principal
Trading Market” means the OTCQB or such other Trading Market on which the Common Stock is primarily listed for trading.

 

“Rule
144” means Rule 144 promulgated by the SEC pursuant to the 1933 Act, as such Rule may be amended from time to time,
or any similar rule or regulation hereafter adopted by the SEC having substantially the same effect as such Rule.

 

“SafeTek”
means SafeTek, LLC, a Utah limited liability company and wholly-owned subsidiary of Company.

 

“Trading
Market” means whichever of the OTCQB, OTCQX, Pink Sheets electronic quotation system or other trading market on
which the Common Stock is listed for trading on the date in question.

 

“Transaction
Documents” means this Agreement, the Notes, the Investor Rights Agreement, the Voting Agreement, the Lock-Up Agreements,
the Security Agreement, the Series B Consent, the Investor Rights Agreement Amendment, the Voting Agreement Amendment, the Security
Agreement Joinder, the Pledge Agreement, and any and all related agreements, instruments, certificates and other documents.

 

    	19

    	 

    

 

SECTION
12. Miscellaneous.

 

12.01
Waivers and Amendments. Upon the approval of the Company and the written consent of the Purchaser, the obligations of the
Company and the rights of the Purchaser under this Agreement may be waived (either generally or in a particular instance, either
retroactively or prospectively and either for a specified period of time or indefinitely). Neither this Agreement, nor any provision
hereof, may be changed, waived, discharged or terminated orally or by course of dealing, but only by an instrument in writing
executed by both the Company and the Purchaser.

 

12.02
Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted to be given
pursuant to this Note shall be in writing and shall be delivered (a) in hand by person with written receipt of the person to whom
such notice is intended; (b) by registered or certified mail, postage prepaid, return receipt requested; or (c) by a generally
recognized commercial courier service or overnight delivery service, (Federal Express or UPS), for next Business Day delivery,
postage prepaid, with delivery receipt requested. All notices sent in accordance with this Section 12.02 shall be deemed
“Delivered” unless otherwise specified herein, the same day if delivered by hand in person with receipt and signature
of the intended recipient or by an authorized officer of the intended recipient; if by registered or certified mail, three (3)
Business Days after the same is deposited in the U.S. Mail; or if sent by a commercial courier service or overnight delivery service
for next Business Day delivery, one (1) Business Day after payment and receipt of mailing. The addresses for such communications
shall be:

 

If
to the Company:

 

Investview,
Inc.

234
Industrial Way West

Building
A, Suite 202

Eatontown,
NJ 07724

Attn:
Joseph Cammarata

Mario
Romano

 

With
a copy to:

 

Michael
Best & Friedrich LLP

170
South Main Street, Suite 1000

Salt
Lake City, UT 84101

Attention:
Kevin C. Timken

 

If
to the Purchaser:

 

DBR
Capital, LLC

1645
Kecks Road

Breinigsville,
PA 18031

Attn:
David B. Rothrock

 

with
copies to:

 

Morgan,
Lewis & Bockius LLP

1701
Market Street

Philadelphia,
Pennsylvania 19103-2921

Attn:
Michael J. Pedrick, Esq.

 

    	20

    	 

    

 

If
to the Purchasing Assignee:

 

Joseph
Cammarata

c/o
Investview, Inc.

234
Industrial Way West

Building
A, Suite 202

Eatontown,
NJ 07724

 

The
addresses of the parties set forth above may be changed from time to time by a party by notice to the other in accordance with
the notice provisions as set forth herein this Section 12.02.

 

12.03
Cumulative Remedies. None of the rights, powers or remedies conferred upon the Purchaser on the one hand or the Company
on the other hand shall be mutually exclusive, and each such right, power or remedy shall be cumulative and in addition to every
other right, power or remedy, whether conferred by this Agreement or now or hereafter available at law, in equity, by statute
or otherwise.

 

12.04
Successors and Assigns. All the terms and provisions of this Agreement shall be binding upon and inure to the benefit of
and be enforceable by the respective parties hereto, the successors and permitted assigns of the Purchaser and the successors
of the Company, whether so expressed or not. None of the parties hereto may assign its rights or obligations hereof without the
prior written consent of the Company, except that the Purchaser may, without the prior consent of the Company, (i) assign its
rights to purchase the Securities hereunder to any of its Affiliates (provided each such Affiliate agrees to be bound by the terms
of this Agreement and makes the same representations and warranties set forth in Section 4 hereof) and (ii) effect its
Assignment Right pursuant to the terms of Section 3.06). This Agreement shall not inure to the benefit of or be enforceable
by any other third party Person.

 

12.05
Headings. The headings of the Sections and paragraphs of this Agreement have been inserted for convenience of reference
only and do not constitute a part of this Agreement.

 

12.06
Governing Law; Jurisdiction. This Agreement shall be governed by and construed in accordance with the laws of the State
of New York without regard to its conflict of law principles. Any suit, action or proceeding seeking to enforce any provision
of, or based on any matter arising out of or in connection with, this Agreement or the transactions contemplated hereby may be
brought in any federal or state court located in the Borough of Manhattan, the City of New York and State of New York, and each
of the parties hereby consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such
suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection which it may now or hereafter
have to the laying of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding
which is brought in any such court has been brought in an inconvenient forum. Process in any such suit, action or proceeding may
be served on any party anywhere in the world, whether within or without the jurisdiction of any such court.

 

12.07 Usury
Laws. It is the intention of the Company and the Purchaser to conform strictly to all applicable usury laws now or
hereafter in force, and any interest payable under this Agreement shall be subject to reduction to the amount not in excess
of the maximum legal amount allowed under the applicable usury laws as now or hereafter construed by the courts having
jurisdiction over such matters. If the maturity of the Notes is accelerated by reason of an election by the Purchaser
resulting from an Event of Default (as defined in the Notes) or otherwise, then earned interest may never include more than
the maximum amount permitted by law, computed from the date hereof until payment, and any interest in excess of the maximum
amount permitted by law shall be canceled automatically and, if theretofore paid, shall at the option of the Purchaser either
be rebated to the Company or credited on the principal amount under this Agreement, or if this Agreement has been
paid, then the excess shall be rebated to the Company. The aggregate of all interest (whether designated as interest, service
charges, points, or otherwise) contracted for, chargeable, or receivable under this Agreement shall under no circumstances
exceed the maximum legal rate upon the unpaid principal balance of this Agreement remaining unpaid from time to time. If such
interest does exceed the maximum legal rate, it shall be deemed a mistake and such excess shall be canceled automatically
and, if theretofore paid, rebated to the Company or credited on the principal amount of this Agreement, or if this Agreement
has been repaid, then such excess shall be rebated to the Company.

 

    	21

    	 

    

 

12.08
Further Assurances. The Company shall, and shall cause its Affiliates to, from time to time at the request of the Purchaser,
without any additional consideration, furnish the Purchaser such further information or assurances; execute and deliver such additional
agreements, documents and instruments; and take such other actions and do such other things, as may be necessary or appropriate
to carry out the terms and provisions of this Agreement and give effect to the transactions contemplated hereby.

 

12.09
Survival. The representations and warranties of the Company and the Purchaser contained in Sections 4 and 5,
and the agreements and covenants set forth in Sections 6, 8 and 12 shall survive the Closing in accordance
with their respective terms.

 

12.10
Counterparts; Effectiveness. This Agreement may be executed in any number of counterparts and by different parties hereto
in separate counterparts, with the same effect as if all parties had signed the same document. All such counterparts (including
counterparts delivered by facsimile or other electronic format) shall be deemed an original, shall be construed together and shall
constitute one and the same instrument. This Agreement shall become effective when each party hereto shall have received counterparts
hereof signed by all of the other parties hereto.

 

12.11
Entire Agreement. This Agreement contains the entire agreement among the parties hereto with respect to the subject matter
hereof and, except as set forth below, this agreement supersedes and replaces all other prior agreements, written or oral, among
the parties hereto with respect to the subject matter hereof, including, for the avoidance of doubt, the Existing Agreement. Notwithstanding
the foregoing or anything to the contrary in this Agreement, this Agreement shall not supersede any confidentiality or other non-disclosure
agreements that may be in place between the Company and the Purchaser.

 

12.12
Severability. If any provision of this Agreement shall be found by any court of competent jurisdiction to be invalid or
unenforceable, the parties hereby waive such provision to the extent that it is found to be invalid or unenforceable. Such provision
shall, to the maximum extent allowable by law, be modified by such court so that it becomes enforceable, and, as modified, shall
be enforced as any other provision hereof, all the other provisions hereof continuing in full force and effect.

 

[Signature
page follows]

 

    	22

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Amended and Restated Securities Purchase Agreement to be duly executed as
of the Effective Date.

 

	 	INVESTVIEW, INC.
	 	 	 
	 	By:	/s/
    Joseph Cammarata
	 	Name:	Joseph
    Cammarata
	 	Title:	Chief
    Executive Officer

 

[Signature
page to Securities Purchase Agreement]

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Amended and Restated Securities Purchase Agreement to be duly executed as
of the Effective Date.

 

	 	DBR CAPITAL, LLC
	 	 	 
	 	By:	/s/
    David B. Rothrock
	 	Name:	David
    B. Rothrock
	 	Title:	Managing
    Member Executive

 

[Signature
page to Securities Purchase Agreement]

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Amended and Restated Securities Purchase Agreement to be duly executed as
of the Effective Date.

 

	 	Solely
    for purposes of Section 3.06 and the other sections expressly referenced therein:
	 	 
	 	/s/
    Joseph Cammarata
	 	Joseph
    Cammarata

 

[Signature
page to Securities Purchase Agreement]

 

    	 

    	 

    

 

EXHIBIT
A

Form
of Note

 

[to
be provided upon request]

 

EXHIBIT
B

Investor
Rights Agreement

 

[to
be provided upon request]

 

EXHIBIT
C

Voting
Agreement

 

[to
be provided upon request]

 

EXHIBIT
D

Lock-Up
Agreement

 

[to
be provided upon request]

 

EXHIBIT
E

Security
Agreement

 

[to
be provided upon request]

 

EXHIBIT
F

Investor
Rights Agreement Amendment

 

[to
be provided upon request]

 

EXHIBIT
G

Voting
Agreement Amendment

 

[to
be provided upon request]

 

EXHIBIT
H

Security
Agreement Joinder

 

[to
be provided upon request]

 

EXHIBIT
I

Pledge
Agreement

 

[to
be provided upon request]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00316-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00316-of-00352.parquet"}]]